158 related articles for article (PubMed ID: 6515422)
1. Cyanotic congenital heart disease in children: hemostatic disorders and relevance of molecular markers of hemostasis.
Suarez CR; Menendez CE; Griffin AJ; Ow EP; Walenga JM; Fareed J
Semin Thromb Hemost; 1984 Oct; 10(4):285-9. PubMed ID: 6515422
[No Abstract] [Full Text] [Related]
2. [Role of disorders of the hemostatic system in the pathogenesis of hemorrhagic vasculitis in children].
Fedorov AV
Vopr Okhr Materin Det; 1979 Jul; 24(7):36-40. PubMed ID: 524785
[No Abstract] [Full Text] [Related]
3. Developmental hemostasis: relevance to hemostatic problems during childhood.
Andrew M
Semin Thromb Hemost; 1995; 21(4):341-56. PubMed ID: 8747697
[TBL] [Abstract][Full Text] [Related]
4. [Chronic widespread intravascular coagulation syndrome and cyanotic congenital cardiopathy. The place of heparin during preoperative period].
Baille Y; Blanc T; Monties JR; Goudard A; Henry E
Presse Med (1893); 1970 Aug; 78(36):1571-4. PubMed ID: 5456287
[No Abstract] [Full Text] [Related]
5. Hemostatic defect in cyanotic and acyanotic congenital heart disease.
Jootar S; Archararit N; Suvachittanont O
J Med Assoc Thai; 1988 Jul; 71(7):382-7. PubMed ID: 3241136
[No Abstract] [Full Text] [Related]
6. The hemostatic mechanism and its defects.
Macfarlane RG
Int Rev Exp Pathol; 1968; 6():55-133. PubMed ID: 4884086
[No Abstract] [Full Text] [Related]
7. Neonatal and maternal hemostasis: value of molecular markers in the assessment of hemostatic status.
Suarez CR; Menendez CE; Walenga JM; Fareed J
Semin Thromb Hemost; 1984 Oct; 10(4):280-4. PubMed ID: 6515421
[No Abstract] [Full Text] [Related]
8. [Changes in the coagulation and anticoagulation system of the blood in patients with congenital defects of the heart of the cyanotic type].
Iufit SE; Zargarli FI; Tolpekin VE
Kardiologiia; 1967 Mar; 7(3):136-7. PubMed ID: 5604602
[No Abstract] [Full Text] [Related]
9. [Study of coagulation factors in cyanotic children with congenital heart defects].
Goldschmidt B
Ann Paediatr; 1966; 207(5):321-8. PubMed ID: 6012677
[No Abstract] [Full Text] [Related]
10. [Blood coagulation tests in cyanotic children with congenital heart defects].
Goldschmidt B
Orv Hetil; 1967 Mar; 108(11):490-2. PubMed ID: 6047071
[No Abstract] [Full Text] [Related]
11. [Blood coagulation tests in children with cyanotic heart defects].
Lenk H; Weissbach G; Bock K; Domula M
Z Gesamte Inn Med; 1975 Dec; 30(23):753-7. PubMed ID: 1224740
[TBL] [Abstract][Full Text] [Related]
12. Cyanotic congenital heart disease (CCHD): focus on hypoxemia, secondary erythrocytosis, and coagulation alterations.
Zabala LM; Guzzetta NA
Paediatr Anaesth; 2015 Oct; 25(10):981-9. PubMed ID: 26184479
[TBL] [Abstract][Full Text] [Related]
13. [Blood coagulation and fibrinolytic enzyme systems during and after extracorporeal circulation].
Goldschmidt B; Böröcz L; Haas M; Büky B
Thoraxchir Vask Chir; 1970 Dec; 18(6):510-9. PubMed ID: 5275551
[No Abstract] [Full Text] [Related]
14. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
[TBL] [Abstract][Full Text] [Related]
15. [Hematopoietic system in cyanotic congenital heart disease].
Lewandowska K; Rachocka J
Pol Tyg Lek; 1968 Dec; 23(51):1984-6. PubMed ID: 4883798
[No Abstract] [Full Text] [Related]
16. Polycythemia in cyanotic heart disease--a study of altered coagulation.
Komp DM; Sparrow AW
J Pediatr; 1970 Feb; 76(2):231-6. PubMed ID: 5410171
[No Abstract] [Full Text] [Related]
17. [Hemorrhagic syndrome caused by hemostasis disorder during of cyanotic congenital heart diseases].
Fouchard J; Chaignon M; Terrier E; Jaulmes B
Coeur Med Interne; 1972; 11(2):407-10. PubMed ID: 5049036
[No Abstract] [Full Text] [Related]
18. [Hemostasis and the pathogenetic classification of coagulation disorders].
Baluda VP
Patol Fiziol Eksp Ter; 1975; (5):3-14. PubMed ID: 1107947
[No Abstract] [Full Text] [Related]
19. Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases.
Osthaus WA; Boethig D; Johanning K; Rahe-Meyer N; Theilmeier G; Breymann T; Suempelmann R
Blood Coagul Fibrinolysis; 2008 Apr; 19(3):220-5. PubMed ID: 18388502
[TBL] [Abstract][Full Text] [Related]
20. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
Walenga JM; Fareed J; Hoppensteadt D
Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
